"Thumbs Down" because I accurately report why the stock is down big-time ?? At the time I posted it, there was no other glue posted on this board why BAX was down. I did not put in any information that was subjective. Just reporting news that was pertaining to BAX that may have been of some opinion to others (but not you). I did not try and justify the news released by JPM. Do you have a better reason why the market is down ??
Seeing how I don't know everything there is to know on this planet, I must to a degree at least evaluate input from sources that make a living in areas where I am a novice. According to a Phase III Study Investigating "Long-Lasting Recombinant Factor VIII Fc Fusion Protein in Hemophilia A“ ....... Eloctate's half-life is 19 hours, 53% more than that of Advate. Disclosure: I own BAX stock and have never owned any BIIB stock.
As reported on Dow Jones wire today (Sept 25 , 2013) ......... JPMorgan starts coverage of Baxter (BAX) at neutral saying the hemophilia drug market, which has traditionally seen little patient movement, is about to become more volatile. Firm says its survey "of 50 hematologists caring for more than 15% of the US market" shows they are becoming increasingly comfortable with new longer-acting products and it expects a larger percentage of patients to switch to new drugs like Biogen's (BIIB) Eloctate than the average Street analyst.